phone icon (917) 310-3371 Request a Prolia evaluation
Nao Medical

Prolia evaluation and injection coordination in NYC

Start with a clinical and records review. Nao Medical confirms the order, safety requirements, medication acquisition, eligible administration clinic, and appointment before any injection is scheduled.

Prolia evaluation and injection coordination Prolia is not a same-day stock service. Do not ship medication or travel to a clinic until the care team confirms the prescriber, product, site, records, and timing.

What the visit can cover

The visit begins with the clinical question and the records that can change the next step.

Healthcare-provider administration

The current Prolia label directs administration by a healthcare provider as a subcutaneous injection every six months.

Advanced kidney disease warning

Prolia has a boxed warning for severe hypocalcemia in patients with advanced chronic kidney disease, especially when CKD-mineral and bone disorder is present.

Dental and calcium review

The clinician reviews oral health and dental plans, corrects pre-existing hypocalcemia, and gives individualized calcium and vitamin D instructions.

No unplanned stopping

Stopping, skipping, or delaying Prolia can increase vertebral-fracture risk. A clinician should plan any transition to another osteoporosis treatment.

How care works

Collect the treatment record

Bring the diagnosis, full DXA reports, prior bone medicines, last Prolia date, outside order if one exists, recent laboratory results, kidney history, medicines, supplements, and dental plans.

Complete the clinical review

The clinician confirms whether the current FDA-approved indication fits and reviews calcium, kidney disease, pregnancy possibility, dental risk, prior reactions, infection history, and continuity needs.

Coordinate medication and site

The care team confirms who prescribes, how the medication is acquired, which clinic can receive and administer it, and when the dose can be scheduled. Availability is not inferred from the general clinic list.

Administer only after confirmation

A trained healthcare professional administers the injection after required records and safety checks are complete and the medication has reached the confirmed clinic.

Plan the next six-month step

Before leaving the care pathway, record the next target date, required monitoring, responsible prescriber, and what to do if coverage, travel, dental work, or health changes may delay treatment.

Prolia requires continuity, not only an injection appointment

Prolia is denosumab, a prescription medicine with several FDA-approved bone-loss indications. The indication, fracture risk, prior therapies, and alternatives need clinician review before the first dose or when transferring care.

The current label includes a boxed warning for severe hypocalcemia in advanced chronic kidney disease. Patients with advanced CKD may need evaluation for chronic kidney disease-mineral and bone disorder and care from a clinician with relevant expertise. A generic injection appointment cannot replace that work.

The plan after a dose matters because the medication is given on a six-month schedule and stopping or delaying it without another treatment plan can raise vertebral-fracture risk. Transfer records should include the exact last-dose date and the clinician responsible for future treatment decisions.

Call before a dose is late or treatment is stopped

Do not stop, skip, or delay Prolia without speaking with the prescribing clinician. Seek prompt medical attention for symptoms that may reflect severe low calcium, a serious allergic reaction, or another urgent problem. Patients with advanced kidney disease need specialist-level risk review under the current boxed warning.

Product, clinic, and appointment must all be confirmed

Book a Prolia evaluation to start the review. The appointment does not promise that Prolia is stocked, accepted from an outside prescriber, covered, or administered at every Nao Medical clinic.

Nao Medical clinic interior

Clinic confirmation

Confirm the right Nao Medical clinic

The care team confirms the visit type and an eligible clinic before any product, procedure, or treatment-specific appointment.

Nao Medical patient visit

Visit preparation

Bring DXA, laboratory, and treatment records

Complete reports and exact prior-dose dates make it easier to review risk, safety, continuity, and the responsible prescriber.

Related care

Choose the related care that matches the question you want the clinician to address.

Osteoporosis evaluation

Review fracture risk, outside DXA results, prior medicines, labs, and treatment or referral options first.

Primary care

Coordinate ongoing conditions, preventive care, records, and referrals through primary care.

Current official medical sources

Sources from DailyMed, FDA, and USPSTF were checked on August 1, 2026.

National Library of Medicine DailyMed

Prolia (denosumab) Current Prescribing Information

Indications, six-month administration, contraindications, laboratory review, dental considerations, and continuity warnings.

Read the official source

U.S. Food and Drug Administration

FDA Boxed Warning for Severe Hypocalcemia With Prolia in Advanced CKD

Advanced kidney disease risk, calcium monitoring, and the warning against stopping or delaying Prolia without clinical guidance.

Read the official source

U.S. Preventive Services Task Force

Osteoporosis to Prevent Fractures: Screening

Current screening recommendation for women 65 and older and younger postmenopausal women at increased risk.

Read the official source

Frequently asked questions

The current prescribing information directs a 60 mg subcutaneous injection every six months, administered by a healthcare provider. The prescriber sets the exact schedule and safety plan.
Do not assume same-day availability. The team must confirm the order, safety records, medication acquisition or delivery, eligible clinic, and appointment before administration.
Bring the outside order, diagnosis, complete DXA reports, the exact last-dose date, recent laboratory results, kidney history, medicine and supplement lists, dental plans, prior reactions, and the outside prescriber's contact information. Nao Medical must still confirm whether it can accept and administer the order.
The FDA boxed warning identifies a higher risk of severe hypocalcemia in advanced chronic kidney disease, especially with CKD-mineral and bone disorder. These patients need appropriate laboratory and specialist review before treatment.
Pre-existing hypocalcemia must be corrected, and the current label includes calcium and vitamin D instructions. The clinician decides which laboratory tests and supplement doses fit the patient's kidney function, diet, medicines, and other risks.
The label calls for an oral examination before initiation and additional dental evaluation for patients with risk factors for osteonecrosis of the jaw. Tell the clinician about dental symptoms and planned extractions or implants.
Do not stop or delay treatment without a clinician-directed transition plan. The current label and FDA safety communication warn about increased vertebral-fracture risk after stopping, skipping, or delaying Prolia.
No all-clinic claim is made. The care team confirms an eligible clinic only after the prescription, product acquisition, records, and staffing requirements are verified.
Nao Medical

Start with the right evaluation

Prolia is not a same-day stock service. Do not ship medication or travel to a clinic until the care team confirms the prescriber, product, site, records, and timing.

Medical content checked against the sources above on August 1, 2026.

Health information notice

General information only. This page is not medical advice and does not replace diagnosis, treatment, or guidance from a licensed clinician.

Content was updated August 1, 2026 from the sources cited on this page. Medical guidance, prescribing information, medication availability, and insurance rules can change. A licensed clinician must confirm current information and determine each patient's eligibility, testing, treatment, administration setting, and follow-up. Call 911 for a medical emergency. Contact Nao Medical with a question or correction.